BACKGROUND: The pyruvic acid analog 3-bromopyruvate (3BrPA) is an alkylating agent known to induce cancer cell death by blocking glycolysis. The anti-glycolytic effect of 3BrPA is considered to be the inactivation of glycolytic enzymes. Yet, there is a lack of experimental documentation on the direct interaction of 3BrPA with any of the suggested targets during its anticancer effect. METHODS AND RESULTS: In the current study, using radiolabeled ((14)C) 3BrPA in multiple cancer cell lines, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was identified as the primary intracellular target of 3BrPA, based on two-dimensional (2D) gel electrophoretic autoradiography, mass spectrometry and immunoprecipitation. Furthermore, in vitro enzyme kinetic studies established that 3BrPA has marked affinity to GAPDH. Finally, Annexin V staining and active caspase-3 immunoblotting demonstrated that apoptosis was induced by 3BrPA. CONCLUSION: GAPDH pyruvylation by 3BrPA affects its enzymatic function and is the primary intracellular target in 3BrPA mediated cancer cell death.
BACKGROUND: The pyruvic acid analog 3-bromopyruvate (3BrPA) is an alkylating agent known to induce cancer cell death by blocking glycolysis. The anti-glycolytic effect of 3BrPA is considered to be the inactivation of glycolytic enzymes. Yet, there is a lack of experimental documentation on the direct interaction of 3BrPA with any of the suggested targets during its anticancer effect. METHODS AND RESULTS: In the current study, using radiolabeled ((14)C) 3BrPA in multiple cancer cell lines, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was identified as the primary intracellular target of 3BrPA, based on two-dimensional (2D) gel electrophoretic autoradiography, mass spectrometry and immunoprecipitation. Furthermore, in vitro enzyme kinetic studies established that 3BrPA has marked affinity to GAPDH. Finally, Annexin V staining and active caspase-3 immunoblotting demonstrated that apoptosis was induced by 3BrPA. CONCLUSION:GAPDH pyruvylation by 3BrPA affects its enzymatic function and is the primary intracellular target in 3BrPA mediated cancer cell death.
Authors: S M El Sayed; R M Abou El-Magd; Y Shishido; S P Chung; T H Diem; T Sakai; H Watanabe; S Kagami; K Fukui Journal: J Bioenerg Biomembr Date: 2012-02-09 Impact factor: 2.945
Authors: Scott M Seki; Max Stevenson; Abagail M Rosen; Sanja Arandjelovic; Lelisa Gemta; Timothy N J Bullock; Alban Gaultier Journal: J Immunol Date: 2017-05-15 Impact factor: 5.422
Authors: Maria V Liberti; Ziwei Dai; Suzanne E Wardell; Joshua A Baccile; Xiaojing Liu; Xia Gao; Robert Baldi; Mahya Mehrmohamadi; Marc O Johnson; Neel S Madhukar; Alexander A Shestov; Iok I Christine Chio; Olivier Elemento; Jeffrey C Rathmell; Frank C Schroeder; Donald P McDonnell; Jason W Locasale Journal: Cell Metab Date: 2017-09-14 Impact factor: 27.287
Authors: Maria V Liberti; Annamarie E Allen; Vijyendra Ramesh; Ziwei Dai; Katherine R Singleton; Zufeng Guo; Jun O Liu; Kris C Wood; Jason W Locasale Journal: J Biol Chem Date: 2019-11-20 Impact factor: 5.157
Authors: Robert T Wicks; Javad Azadi; Antonella Mangraviti; Irma Zhang; Lee Hwang; Avadhut Joshi; Hansen Bow; Marianne Hutt-Cabezas; Kristin L Martin; Michelle A Rudek; Ming Zhao; Henry Brem; Betty M Tyler Journal: Neuro Oncol Date: 2014-07-22 Impact factor: 12.300